Target intelligence / Profile preview

Beta-lactamase (class A, class C, and class D variants)

Molecular classification
Enzyme, Serine hydrolase, Beta-lactamase family, Antibiotic resistance factor
01

Overview

Beta-lactamases are bacterial enzymes classified into molecular classes (A, C, and D) based on amino acid sequence and function; all use a serine residue at their active site to hydrolyze beta-lactam antibiotics, conferring resistance to penicillins, cephalosporins, carbapenems, and monobactams depending on type. Class A enzymes include common ESBLs (TEM, SHV, CTX-M, KPC), class C enzymes are largely cephalosporinases (AmpC-type), and class D includes diverse OXA-type enzymes. These enzymes represent a major mechanism of acquired and intrinsic antibiotic resistance among clinically significant bacteria; inhibitors such as clavulanic acid, tazobactam, and avibactam are used to restore antibiotic activity against some enzyme types, although resistance continues to evolve, presenting major challenges in infectious disease therapy and patient safety.

Other names
PenicillinaseCephalosporinase (class C)Serine beta-lactamaseESBLs (Extended-Spectrum Beta-Lactamases; for some class A/D)AmpC (class C)OXA-type beta-lactamase (for some class D)KPC, SHV, TEM, CTX-M (examples of class A beta-lactamases)
02

Mechanism of action

Beta-lactam antibiotics: bind and are hydrolyzed/inactivated unless the enzyme is inhibited or overcome. Beta-lactamase inhibitors: bind and inhibit the enzyme, restoring antibiotic efficacy.

03

Biological functions

Antibiotic hydrolysisBacterial cell wall protection
04

Disease associations

InfectionAntimicrobial resistance phenomena
05

Safety considerations

Rapid emergence of resistanceSpread via plasmids and transposonsLimited number of effective inhibitors for all enzyme classesDetection challenges and treatment failures
06

Interacting drugs

Penicillins

7 more in the full profile.

07

Biomarkers

Presence of specific beta-lactamase genesPhenotypic resistance patterns in clinical microbiology

Beyond the preview

Go deeper on Beta-lactamase (class A, class C, and class D variants).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-lactamase (class A, class C, and class D variants).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call